New Depression Data Has Been Reported by a Researcher at Tri-Service General Hospital (Bupropion Associated Immunomodulatory Effects on Peripheral Cytokines in Male with Major Depressive Disorder).

A recent study conducted at Tri-Service General Hospital in Taipei, Taiwan, explored the immunomodulatory effects of the antidepressant bupropion on patients with major depressive disorder (MDD). The study involved 18 MDD patients who were treated with bupropion for four weeks, as well as 23 healthy volunteers. The results showed that bupropion treatment significantly increased the levels of certain cytokines, including IL-1b, IL-4, IL-5, IL-7, and IL-8, compared to the control group. The study suggests that the promotion of anti-inflammatory cytokines may be a crucial step in the treatment of MDD patients with bupropion. [Extracted from the article]

Copyright of Mental Health Weekly Digest is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)